KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2018 - 2025)

ClearPoint Neuro's Depreciation & Amortization (CF) history spans 13 years, with the latest figure at $360000.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 36.36% year-over-year to $360000.0; the TTM value through Sep 2025 reached $1.0 million, down 10.99%, while the annual FY2024 figure was $923000.0, 11.07% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $360000.0 at ClearPoint Neuro, up from $230000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $388000.0 in Q4 2023 and bottomed at -$156000.0 in Q4 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $183000.0 (2023), against an average of $176421.1.
  • The largest YoY upside for Depreciation & Amortization (CF) was 786.67% in 2022 against a maximum downside of 217.29% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $133000.0 in 2021, then tumbled by 217.29% to -$156000.0 in 2022, then skyrocketed by 348.72% to $388000.0 in 2023, then crashed by 52.84% to $183000.0 in 2024, then soared by 96.72% to $360000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Depreciation & Amortization (CF) are $360000.0 (Q3 2025), $230000.0 (Q2 2025), and $231000.0 (Q1 2025).